UPDATE 1-U.S. FDA panel backs Celltrion copycat of Roche blood cancer drug

Celltrion Pharm Inc's biosimilar of Roche Holding AG's blockbuster cancer drug, Rituxan, on Wednesday won unanimous backing from an advisory panel to the U.S. Food and Drug Administration.

https://ift.tt/2EevXSK support@endlesssupplies.biz (Endless Supplies .Biz) October 10, 2018 at 01:02PM